Sadhana Nitro Chem and Deepak Nitrite: two chemical stories, two different risks

Where the checklist falls short

Sadhana has fresh order evidence, but too much depends on recovering cash tied up in its balance sheet and establishing profitable operations. Deepak is the stronger candidate for further research, with an existing operating business and credible expansion plans. Neither made it into the model at the report date. The central question is whether the capital already invested, or still to be invested, can earn an attractive return at the price being paid.

What could change my mind

For Sadhana, I need evidence of collections, sustainable margins and cash conversion. For Deepak, I want a reconciled capex and funding schedule, customer commitments that become recurring sales, and evidence that the new assets can earn their cost of capital through an ordinary industry cycle.